Oorsprong van het eerstegraads netwerk van Christoph von Basel
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
SenTec AG
 SenTec AG Electronic Equipment/InstrumentsElectronic Technology SenTec AG develops and markets medical related products. The company was founded on July 15, 1999 and is headquartered in Therwil, Switzerland.
4
| Private Company | Electronic Equipment/Instruments | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Christoph von Basel via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| STRAUMANN HOLDING AG | Medical Specialties | Director/Board Member | |
| Boston University | College/University | Masters Business Admin | |
| Stratec Medical AGs | Corporate Officer/Principal | ||
| University of Basel | College/University | Undergraduate Degree | |
| SYMETIS SA | Biotechnology | Chairman | |
Endeavour Vision SA
 Endeavour Vision SA Investment ManagersFinance Endeavour Vision SA (EV) is an independent venture capital firm headquartered in Geneva. EV traces their origins back to 1989 through the convergence of the Vision Capital European team and the Swiss VC firm, Endeavour. EV was co-founded in 2000 by Sven Lingjaerde and Damien Tappy. The firm specializes in providing funding for entrepreneurs in life sciences, biotech, medtech, cleantech and information technology. EV operates in close cooperation with Genevest, an independent investment vehicle which has reached the divestment stage. Their investors in the funds they advise are industrial corporations, family offices, global institutional investors and business leaders in the technology and investment industry. | Investment Managers | Corporate Officer/Principal | |
| Graduate School of Business Administration Zürich | College/University | Masters Business Admin | |
| MEDARTIS HOLDING AG | Medical Specialties | Director/Board Member | |
| Kuros Therapeutics AG | Founder | ||
Qgel SA
 Qgel SA BiotechnologyHealth Technology Qgel SA engages in drug discovery. The private company is based in Lausanne, Switzerland. The Swiss company was founded in 2009 by Matthias Lütolf and Colin Sanctuary. Colin Sanctuary has been the CEO since 2009. | Biotechnology | Chairman | |
| Senspec GmbH | Chairman | ||
| KUROS BIOSCIENCES AG | Biotechnology | Director/Board Member | |
| Nexmed Holding AG | Chairman | ||
| Le Grand Hotel Chandolin SA | Chairman | ||
Kuros Biosciences AG
 Kuros Biosciences AG Miscellaneous Commercial ServicesCommercial Services Kuros Biosciences AG is a Swiss company that specializes in developing innovative solutions for targeted and controlled bone healing. The private company is based in Schlieren, Switzerland. The company's mission is to eliminate non-unions and improve patient rehabilitation. | Miscellaneous Commercial Services | Director/Board Member | |
| Medartis AG | Director/Board Member | ||
| Protek AG | Sales & Marketing |
Statistieken
Internationaal
| Zwitserland | 17 |
| Duitsland | 3 |
| Israël | 2 |
Sectoraal
| Health Technology | 7 |
| Consumer Services | 4 |
| Commercial Services | 3 |
| Finance | 2 |
Operationeel
| Director/Board Member | 10 |
| Chairman | 8 |
| Corporate Officer/Principal | 3 |
| Founder | 2 |
| Sales & Marketing | 2 |
Sterkste connecties
| Insiders | |
|---|---|
| Dominik Ellenrieder | 20 |
| Konrad Georg | 1 |
| Dominik von Basel | 1 |
| Josef von Fribourg | 1 |
- Beurs
- Insiders
- Christoph von Basel
- Bedrijfsconnecties
